Clinical Trial

Replacement of the Native Mitral Valve Using the ReValve System

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study is to collect preliminary chronic information on performance and safety of the ReValve System.
Trial Details
NCT Number NCT07601269
Lead Sponsor ReValve Solutions Inc.
Conditions Mitral Valve Replacement
Enrollment 25 participants
Start Date 2026-04-26
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-22